IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 154 filers reported holding IVERIC BIO INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,846,396 | +59.2% | 148,612 | -1.5% | 0.01% | +60.0% |
| Q1 2023 | $3,672,054 | +12.2% | 150,927 | -1.3% | 0.01% | 0.0% |
| Q4 2022 | $3,273,139 | +56.0% | 152,879 | +30.7% | 0.01% | +25.0% |
| Q3 2022 | $2,098,000 | +84.2% | 116,925 | -1.3% | 0.00% | +100.0% |
| Q2 2022 | $1,139,000 | -42.7% | 118,439 | +0.3% | 0.00% | -33.3% |
| Q1 2022 | $1,988,000 | -4.2% | 118,118 | -4.9% | 0.00% | +50.0% |
| Q4 2021 | $2,076,000 | +15.7% | 124,158 | +12.3% | 0.00% | 0.0% |
| Q3 2021 | $1,795,000 | +127.5% | 110,554 | -11.5% | 0.00% | +100.0% |
| Q2 2021 | $789,000 | +5.1% | 124,988 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $751,000 | -10.6% | 121,573 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $840,000 | +22.4% | 121,573 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $686,000 | +97.7% | 121,573 | +78.8% | 0.00% | 0.0% |
| Q2 2020 | $347,000 | – | 68,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |